Paxlovid: Eine spezifische Interventionsoption

from PZ-Nachgefragt - für die Apotheke · host Pharmazeutische Zeitung

Mit Paxlovid hat die pharmazeutische Forschung das erste und bisher einzige SARS-CoV-2-spezifische Medikament entwickelt und in den Markt gebracht.

Episode metadata supplied by the publisher feed · Published Aug 4, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Paxlovid: Eine spezifische Interventionsoption

0:00 12:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 12 minutes long.

This episode was published on August 4, 2022.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!